J&J signs vaccine finishing deal with Grand River To view this email as a web page,
click here | | Webinar: Digitize Remote Site Monitoring with Box Tuesday, October 13 | 2pm ET / 11am PT Fierce Pharma is teaming up with Box to discuss how your life sciences organization can continue to propel therapies & devices through the value chain with faster and even more secure site monitoring and auditing. Accelerate R&D processes across the value chain, maintain GxP compliance and reduce your overall IT footprint. Register Today! |
Trump administration may push back info blocking rule again due to COVID-19 pandemic Orgenesis inks Koligo buyout to gain COVID-19 cell therapy Johnson & Johnson signs on Michigan's Grand River to help with COVID-19 vaccine finishing work Insurers offered new benefits in response to COVID-19. Where do they stand 6 months later? FDA authorizes Hologic's high-throughput COVID-19 test for wider screening of people showing no symptoms Blue Cross NC teams up with North Carolina providers, experts to manufacture N95 masks Biopharma roundup: SII steps up to produce 100M more COVAX doses Healthcare roundup: HHS details plan to deploy 150M rapid COVID-19 tests Featured Story | By Heather Landi The Trump administration is planning to delay the compliance deadlines for healthcare interoperability regulations for a second time due to the COVID-19 pandemic. read more |
| |
|---|
|
Top Stories By Nick Paul Taylor Orgenesis has struck a deal to acquire Koligo Therapeutics. The takeover will give Orgenesis control of an autologous cell therapy treatment for respiratory disease caused by COVID-19. read more By Kyle Blankenship With all eyes on the hunt for a COVID-19 vaccine, drugmakers like New Jersey's Johnson & Johnson are scouring the market for manufacturing partners to help meet what would be global demand for their shots. With a couple already in hand, J&J is now turning to a Michigan CDMO to help keep up. read more By Paige Minemyer Here's a look at the status of some of the benefits—such as telehealth coverage—that major national insurers rolled out earlier this year. read more By Conor Hale The agency also gave the company’s diagnostic, run on the high-throughput Panther Fusion laboratory platform, a green light for pooled testing. read more By Paige Minemyer Blue Cross and Blue Shield of North Carolina is teaming up with prominent providers and companies in the state to manufacture N95 respirators for healthcare workers. read more By Eric Sagonowsky, Angus Liu, Kyle Blankenship, Conor Hale, Fraiser Kansteiner Serum Institute of India will churn out 100 million more vaccine doses for distribution through COVAX. Orgenesis snagged a COVID-19 cell therapy through its Koligo acquisition. Windtree got the OK to launch a phase 2 trial of its synthetic surfactant. And Russia is gearing up to release interim phase 3 vaccine data. read more By Healthcare Staff Follow along with the latest COVID-19 news straight from the Fierce Healthcare team. read more |
|
